Selected references

Alternate TextBack

BIOLOGICS FACILITY TO THE US

State-of-the-art modular manufacturing facility for monoclonal antibodies, mAbs.

  • Delivered to: USA
  • Completed: 2020
  • Size: 7 100 sqm
  • Scope: Complete modular manufacturing building including upstream and downstream processing.
arrow

This website uses cookiesfor statistics and user experience.

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.

Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.

Cookies